Revolutionizing Healthcare: The Future of Multi-Organ Chips
Written on
Chapter 1: Introduction to Multi-Organ Chips
The newly developed multi-organ chip is comparable in size to a glass microscope slide and is capable of cultivating up to four distinct human-engineered tissues. The arrangement and number of these tissues can be customized based on specific research inquiries. These tissues are interconnected through a vascular system, while a selectively permeable endothelial barrier preserves their unique tissue environments.
I often emphasize how technology's most exciting applications lie within the healthcare sector. Recent innovations in health tech have demonstrated this potential, such as the immune system on a chip created by researchers at Harvard, which successfully replicates human immune responses. These advancements inspire hope for a future where treatments can be tailored to individual patients using devices specifically designed for their physiological needs.
Section 1.1: A Breakthrough in Organ Modeling
One of the most significant projects, a decade in development, is now nearing completion. Researchers have faced challenges in modeling bodily functions and complex diseases using multiple engineered tissues that can communicate with one another physiologically. Until recently, no one had successfully managed to achieve this dual functionality.
A team from Columbia University has introduced a plug-and-play multi-organ chip composed of engineered human tissues—heart, bone, liver, and skin—that are interconnected through vascular flow and circulating immune cells. This innovation allows for the recreation of the interdependent functions of various organs, all contained within a device the size of a microscope slide that can be tailored to reflect a patient's specific physiology.
Video Description: This video features Gordana Vunjak-Novakovic discussing the advancements in organ engineering and the implications for future medical treatments.
“After ten years of research on organs-on-chips, we are still amazed that we can model a patient’s physiology by connecting millimeter-sized tissues — the beating heart muscle, the metabolizing liver, and the functioning skin and bone that are grown from the patient’s cells. We are excited about the potential of this approach.”
— Gordana Vunjak-Novakovic, Project Leader
Section 1.2: A Personalized Approach to Medicine
This groundbreaking technology could become an essential tool in future medicine, addressing the unique needs of patients as disease progression and treatment responses vary individually. Such personalized strategies could significantly enhance the effectiveness of therapies and medications. The researchers have spent a decade perfecting this platform, which has successfully captured the interactions between organs as they function within the human body.
The inspiration for this innovative system arose from the human biological network, with the team constructing a tissue-chip system that links mature heart, liver, bone, and skin tissues via a recirculating vascular flow. This setup enables the organs to interact just as they do naturally in the body, all while maintaining their specific environments.
The team successfully created tissue modules within optimized settings, separated from vascular flow by a permeable endothelial barrier, which allowed for effective communication among the tissues. All tissues were derived from the same line of human-induced pluripotent stem cells (iPSC) obtained from a small blood sample. Remarkably, the tissue-chip system was maintained for up to 10 weeks, covering everything from creation to vascular perfusion.
Subsection 1.2.1: Drug Testing and Future Applications
During their experiments, the researchers examined the effects of doxorubicin, a common anticancer medication, on the heart, liver, bone, skin, and vascular systems. The outcomes mirrored findings from clinical studies, validating the chip's effectiveness. They also developed a computational model of the multi-organ chip to simulate drug absorption, distribution, metabolism, and excretion.
The team believes their invention and the computational methods employed could significantly advance drug development processes in the future. They are currently working on various chip versions to explore a wide range of conditions, including breast cancer metastasis, prostate cancer, leukemia, and the effects of radiation on human tissues.
Video Description: This video explores how organ-chips serve as a novel tool for drug discovery and biological research.
To fully realize the innovation's potential, the team is also developing standardized chips for both academic and clinical environments. The complete research findings have been published in the Journal of Nature Biomedical Engineering.
Stay updated with more insights like this by subscribing to my weekly newsletter.